Andra Ap Fonden Novo Cure LTD Transaction History

Andra Ap Fonden

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $237,048 - $499,002	4,200 New	4,200 $252,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $151,021 - $252,915	-1,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $365,120 - $631,624	-2,800 Reduced 68.29%	1,300 $288,000
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $124,110 - $190,170	-1,000 Reduced 19.61%	4,100 $542,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $572,016 - $888,113	5,100 New	5,100 $883,000

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.